{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-16T20:13:48.796634+00:00","company":{"ticker":"RTGN","cik":1836295,"company_name":"RetinalGenix Technologies Inc."},"pagination":{"limit":100,"returned":3,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"executive_change","fact_key":"070b690f92","cik":1836295,"ticker":"RTGN","company_name":"RetinalGenix Technologies Inc.","filed_at":"2023-12-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-12-04","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Dessislava Boneva was appointed as director at RetinalGenix Technologies Inc..","evidence_excerpt":"On December 4, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Ms. Dessislava (Dessy) Boneva M.D. FACS, to serve as a director of the Company.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-23-043870","anchor_url":"https://secwatch.observer/filing/0001493152-23-043870#claim-070b690f92","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1836295/000149315223043870/0001493152-23-043870-index.htm"},{"fact_type":"executive_change","fact_key":"42a5f473a4","cik":1836295,"ticker":"RTGN","company_name":"RetinalGenix Technologies Inc.","filed_at":"2023-12-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-11-30","interim":true,"role":"Interim Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Virender Ahluwalia was appointed as Interim Chief Financial Officer at RetinalGenix Technologies Inc..","evidence_excerpt":"On November 30, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Virender Ahluwalia to serve as Interim Chief Financial Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-043522","anchor_url":"https://secwatch.observer/filing/0001493152-23-043522#claim-42a5f473a4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1836295/000149315223043522/0001493152-23-043522-index.htm"},{"fact_type":"executive_change","fact_key":"835c0d95e3","cik":1836295,"ticker":"RTGN","company_name":"RetinalGenix Technologies Inc.","filed_at":"2022-07-28T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-07-25","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Vinay Mehindru was appointed as director at RetinalGenix Technologies Inc..","evidence_excerpt":"On July 25, 2022, the Board of Directors (the “Board”) of RetinalGenix Inc. (the ‘Company”) appointed Vinay Mehindru, MD, MBA to serve as a director of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-22-020481","anchor_url":"https://secwatch.observer/filing/0001493152-22-020481#claim-835c0d95e3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1836295/000149315222020481/0001493152-22-020481-index.htm"}]}